Table 1. Patient Characteristics.
| Variable | |
|---|---|
| N | 68 |
| Median Age in Years (Range) | 37 (4-75) |
| Sex | 45 male/23 female |
| Diagnosis | |
| CML or MPD | 22 |
| AML/ALL | 17/10 |
| Lymphoma/CLL | 13/4 |
| Aplastic Anemia | 2 |
| Median Months from Diagnosis to SCT (range) | 31 (2-369) |
| Donor Type | |
| 6/6 Related | 16 |
| Mismatched Related | 15 |
| 6/6 Unrelated | 31 |
| Mismatched Unrelated | 6 |
| Conditioning Regimen | |
| TBI + Other | 37 |
| Other Ablative | 8 |
| Non Ablative or Reduced Intensity | 23 |
| GVHD Prophylaxis | |
| Tacrolimus +/- other | 40 |
| Cyclosporine +/- other | 20 |
| T cell depletion | 8 |
| Stem Cell Source | |
| Bone Marrow | 36 |
| Peripheral Blood | 29 |
| Cord Blood | 3 |
N: number; CML: Chronic Myelogenous Leukemia; MPD: Myeloproliferative disorder; AML: Acute Myelogenous Leukemia; ALL; Acute Lymphoblastice Leukemia; CLL: Chronic Lymphocytic Leukemia; SCT: Stem cell transplant.